Pre-earnings options volume in Emergent BioSolutions is 2.6x normal with puts leading calls 5:2. Implied volatility suggests the market is anticipating a move near 36.4%, or $1.17, after results are released. Median move over the past eight quarters is 9.5%.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EBS:
- Emergent BioSolutions options imply 25.1% move in share price post-earnings
- Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
- Biotech Alert: Searches spiking for these stocks today
- Emergent Biosolutions Welcomes Joseph Papa as New CEO
- Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO